HLS Therapeutics Inc. (HLTRF)
HLTRF Stock Price Chart
Explore HLS Therapeutics Inc. interactive price chart. Choose custom timeframes to analyze HLTRF price movements and trends.
HLTRF Company Profile
Discover essential business fundamentals and corporate details for HLS Therapeutics Inc. (HLTRF) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
27 Jan 2010
Employees
92.00
Website
https://www.hlstherapeutics.comCEO
Craig Stuart Millian
Description
HLS Therapeutics Inc., a specialty pharmaceutical company, acquires and commercializes pharmaceutical products in the specialty central nervous system and cardiovascular (CV) markets in Canada, the United States, and internationally. The company's product portfolio includes Clozaril, an atypical antipsychotic used in the treatment of schizophrenia; Vascepa, an icosapent ethyl capsules; and PERSERIS, an injectable risperidone product for the treatment of schizophrenia. It also offers MyCare psychiatry lab assays and MyCare Insite point of care therapeutic drug-level monitoring tests. In addition, the company holds the U.S. marketing rights of Absorica, a commercial stage dermatology product; Canadian rights of Trinomia for CV therapeutics; and a portfolio of royalty interests of four healthcare products. HLS Therapeutics Inc. was founded in 2018 and is headquartered in Etobicoke, Canada.
HLTRF Financial Timeline
Browse a chronological timeline of HLS Therapeutics Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 6 May 2026
Upcoming earnings on 11 Mar 2026
Upcoming earnings on 13 Nov 2025
Revenue estimate is $14.40M.
Earnings released on 14 Aug 2025
EPS came in at -$0.09 falling short of the estimated -$0.07 by -15.92%, while revenue for the quarter reached $14.17M , missing expectations by -2.00%.
Earnings released on 8 May 2025
EPS came in at -$0.14 falling short of the estimated -$0.12 by -16.49%, while revenue for the quarter reached $12.62M , beating expectations by +0.82%.
Earnings released on 13 Mar 2025
EPS came in at -$0.10 falling short of the estimated -$0.09 by -7.59%, while revenue for the quarter reached $15.54M , beating expectations by +15.99%.
Earnings released on 7 Nov 2024
EPS came in at -$0.15 falling short of the estimated -$0.12 by -22.01%, while revenue for the quarter reached $14.09M , missing expectations by -10.29%.
Earnings released on 8 Aug 2024
EPS came in at -$0.18 falling short of the estimated -$0.15 by -17.26%, while revenue for the quarter reached $14.52M , beating expectations by +1.94%.
Earnings released on 9 May 2024
EPS came in at -$0.19 falling short of the estimated -$0.16 by -19.92%, while revenue for the quarter reached $12.42M , missing expectations by -14.72%.
Earnings released on 14 Mar 2024
EPS came in at -$0.17 falling short of the estimated -$0.10 by -82.68%, while revenue for the quarter reached $16.30M , beating expectations by +1.88%.
Earnings released on 9 Nov 2023
EPS came in at -$0.21 falling short of the estimated -$0.11 by -100.47%, while revenue for the quarter reached $16.04M , missing expectations by -2.45%.
Earnings released on 10 Aug 2023
EPS came in at -$0.29 falling short of the estimated -$0.12 by -141.14%, while revenue for the quarter reached $16.42M , beating expectations by +3.25%.
Earnings released on 11 May 2023
EPS came in at -$0.18 falling short of the estimated -$0.12 by -51.67%, while revenue for the quarter reached $14.76M , missing expectations by -7.20%.
Earnings released on 16 Mar 2023
EPS came in at -$0.20 falling short of the estimated -$0.07 by -185.71%, while revenue for the quarter reached $15.68M , missing expectations by -3.72%.
Dividend declared on 15 Mar 2023
A dividend of $0.04 per share was announced, adjusted to $0.04. The dividend was paid on 15 Jun 2023.
Earnings released on 10 Nov 2022
EPS came in at -$0.14 falling short of the estimated -$0.13 by -7.69%, while revenue for the quarter reached $15.70M , missing expectations by -5.68%.
Dividend declared on 9 Nov 2022
A dividend of $0.04 per share was announced, adjusted to $0.04. The dividend was paid on 15 Mar 2023.
Earnings released on 11 Aug 2022
EPS came in at -$0.28 falling short of the estimated -$0.07 by -300.00%, while revenue for the quarter reached $15.53M , missing expectations by -6.62%.
Dividend declared on 10 Aug 2022
A dividend of $0.04 per share was announced, adjusted to $0.04. The dividend was paid on 15 Dec 2022.
Earnings released on 5 May 2022
EPS came in at -$0.11 falling short of the estimated -$0.10 by -10.00%, while revenue for the quarter reached $14.56M , missing expectations by -6.97%.
Dividend declared on 4 May 2022
A dividend of $0.04 per share was announced, adjusted to $0.04. The dividend was paid on 15 Sept 2022.
Dividend declared on 21 Mar 2022
A dividend of $0.04 per share was announced, adjusted to $0.04. The dividend was paid on 15 Jun 2022.
Earnings released on 17 Mar 2022
EPS came in at -$0.13 falling short of the estimated -$0.10 by -30.00%, while revenue for the quarter reached $15.69M , missing expectations by -4.44%.
Earnings released on 4 Nov 2021
EPS came in at -$0.06 surpassing the estimated -$0.11 by +45.45%, while revenue for the quarter reached $15.06M .
Dividend declared on 3 Nov 2021
A dividend of $0.04 per share was announced, adjusted to $0.04. The dividend was paid on 15 Mar 2022.
Earnings released on 5 Aug 2021
EPS came in at -$0.07 surpassing the estimated -$0.15 by +53.33%, while revenue for the quarter reached $14.95M .
Dividend declared on 5 Aug 2021
A dividend of $0.04 per share was announced, adjusted to $0.04. The dividend was paid on 15 Dec 2021.
Dividend declared on 29 Jul 2021
A dividend of $0.04 per share was announced, adjusted to $0.04. The dividend was paid on 15 Sept 2021.
Earnings released on 6 May 2021
EPS came in at -$0.15 matching the estimated -$0.15, while revenue for the quarter reached $14.31M .
Earnings released on 18 Mar 2021
EPS came in at -$0.25 falling short of the estimated -$0.06 by -316.67%, while revenue for the quarter reached $16.49M .
Dividend declared on 17 Mar 2021
A dividend of $0.04 per share was announced, adjusted to $0.04. The dividend was paid on 15 Jun 2021.
Earnings released on 5 Nov 2020
EPS came in at -$0.05 surpassing the estimated -$0.14 by +64.29%, while revenue for the quarter reached $13.13M .
Dividend declared on 4 Nov 2020
A dividend of $0.04 per share was announced, adjusted to $0.04. The dividend was paid on 15 Mar 2021.
Dividend declared on 5 Aug 2020
A dividend of $0.04 per share was announced, adjusted to $0.04. The dividend was paid on 15 Dec 2020.
HLTRF Stock Performance
Access detailed HLTRF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.